Literature DB >> 26163597

Risk Factors and Epidemiology of Gastric Cancer in Pakistan.

Muhammad Daniyal1, Saeed Ahmad, Mukhtiar Ahmad, Hafiz Muhammad Asif, Muhammad Akram, Saif Ur Rehman, Sabira Sultana.   

Abstract

Gastric cancer is the 2nd most common cause of death among all cancers and is the 4th most common cancer in the world. The number of deaths due to gastric cancer is about 800,000 annually. Gastric cancer is more common in men as compared to women and is 3rd most common cancer after colorectal and breast cancers in women. A progressive rise in the incidence rate has been observed in females over the last 5 years. The highest incidence of stomach cancer is in China, South America and Eastern Europe. The incidence of gastric cancer has 20 fold variation worldwide. Global variation is linked by two factors which play important role in developing gastric cancer. One is infection with Helicobacter pylori and the 2nd is diet. South Asia is a region with low risk, despite a high prevalence of H.pylori. Gastric carcinoma is common in southern region of India. Gastric cancer is more readily treated if diagnosed early. This study aims to provide awareness about gastric cancer as well as an updated knowledge about risk factors and epidemiology of gastric cancer in Pakistan.

Entities:  

Mesh:

Year:  2015        PMID: 26163597     DOI: 10.7314/apjcp.2015.16.12.4821

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.

Authors:  Gang Hu; Ningjie Sun; Jiansong Jiang; Xiansheng Chen
Journal:  Cancer Cell Int       Date:  2020-09-03       Impact factor: 5.722

2.  Comparison of rural practice in relation to upper gastrointestinal endoscopy.

Authors:  Kazuhiko Kotani
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

3.  Interleukins 17 and 23 in patients with gastric neoplasms.

Authors:  Wojciech Błogowski; Anna Madej-Michniewicz; Natalia Marczuk; Barbara Dołęgowska; Teresa Starzyńska
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

Review 4.  Risk Factors for Gastric Cancer: A Systematic Review

Authors:  Ali Reza Yusefi; Kamran Bagheri Lankarani; Peivand Bastani; Zahra Kavosi
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

5.  The Association Between AURKA Gene rs2273535 Polymorphism and Gastric Cancer Risk in a Chinese Population.

Authors:  Xiaoyan Zhou; Pengli Wang; Hui Zhao
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

6.  Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.

Authors:  Ruihong Zhao; Lei Zhao; Xu Xu; Hong Xu
Journal:  Oncol Rep       Date:  2019-03-07       Impact factor: 3.906

7.  Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer.

Authors:  Shujing Xia; Qi Tang; Xudong Wang; Lili Zhang; Lizhou Jia; Duo Wu; Pingxiang Xu; Xiumei Zhang; Genxiong Tang; Tingting Yang; Zhenqing Feng; Lungen Lu
Journal:  Oncol Lett       Date:  2019-09-19       Impact factor: 2.967

8.  Occurrence of Helicobacter Pylori in Specimens of Chronic Gastritis and Gastric Adenocarcinoma Patients: A Retrospective Study at University Teaching Hospital, Kigali, Rwanda.

Authors:  Theoneste Nizeyimana; Belson Rugwizangoga; Felix Manirakiza; Alvaro C Laga
Journal:  East Afr Health Res J       Date:  2021-11-15

9.  BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.

Authors:  Guodong Lian; Leping Li; Yulong Shi; Changqing Jing; Jinglei Liu; Xiaobo Guo; Qingqing Zhang; Tianyu Dai; Fei Ye; Yanyan Wang; Man Chen
Journal:  Int J Oncol       Date:  2018-01-25       Impact factor: 5.650

10.  Association between the SNPs of the TOB1 gene and gastric cancer risk in the Chinese Han population of northeast China.

Authors:  Hui Wang; Huiting Hao; Haonan Guo; Yuanyuan Wang; Xuelong Zhang; Lidan Xu; Jingcui Yu
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.